IRIS
BUEMI, MARIAROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 911
EU - Europa 755
AS - Asia 359
AF - Africa 3
SA - Sud America 1
Totale 2.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 911
IE - Irlanda 255
SE - Svezia 229
CN - Cina 225
IT - Italia 139
SG - Singapore 105
FI - Finlandia 31
IN - India 23
DE - Germania 22
BE - Belgio 21
GB - Regno Unito 20
UA - Ucraina 18
CZ - Repubblica Ceca 10
VN - Vietnam 3
JP - Giappone 2
MA - Marocco 2
RO - Romania 2
AT - Austria 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
GR - Grecia 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 2.029
Salva come PNG Salva come JPEG
Città #
Dublin 255
Chandler 190
Nyköping 168
Beijing 87
Singapore 87
Ashburn 84
Ann Arbor 75
Jacksonville 69
Messina 68
Princeton 40
Medford 36
Cambridge 33
Des Moines 26
Dearborn 23
Jinan 23
Boardman 20
Brussels 19
Hyderabad 16
San Mateo 14
Shenyang 14
Wilmington 14
Catania 11
Ningbo 11
Woodbridge 11
Francofonte 10
Brno 8
Fuzhou 8
Haikou 8
Seattle 8
Taizhou 8
Pune 7
Guangzhou 6
Hangzhou 6
Hebei 6
Jiaxing 6
New York 6
Tianjin 6
Lancaster 5
Nanjing 5
Los Angeles 4
Munich 4
Nanchang 4
Washington 4
Chicago 3
Clearwater 3
Helsinki 3
Ho Chi Minh City 3
Houston 3
Rome 3
Zhengzhou 3
Borghetto Santo Spirito 2
Carugate 2
Fiorenzuola D'arda 2
Guspini 2
Naples 2
Olomouc 2
Shanghai 2
Taiyuan 2
Torino 2
Acton 1
Agadir 1
Athens 1
Austin 1
Bratislava 1
Brooklyn 1
Changsha 1
Chatsworth 1
Dalian 1
Den Haag 1
Durban 1
Halle 1
Hanover 1
Jeffries 1
Kaifeng 1
Kunming 1
London 1
Milan 1
Norwalk 1
Novokuznetsk 1
Palermo 1
Parma 1
Petaling Jaya 1
Prato 1
Qingdao 1
Rende 1
Santa Clara 1
Sassari 1
Tappahannock 1
The Dalles 1
Viagrande 1
Vienna 1
Xi'an 1
Xiangfen 1
Xinxiang 1
Zurich 1
Totale 1.588
Salva come PNG Salva come JPEG
Nome #
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 104
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 96
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 92
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 82
Graphene Quantum Dots Based Systems As HIV Inhibitors 81
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 73
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 70
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 70
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 67
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 66
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 65
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 63
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 59
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 58
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 58
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 58
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 55
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 55
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 53
Progettazione e sintesi di antagonisti non competitivi del recettore NR2B/NMDA 52
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 52
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 50
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives 50
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 49
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 49
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 46
Design, Synthesis and Biostructural Characterization of Carbonic Anhydrase Inhibitors 45
Identification of 3-substituted-1H-indoles as ligands of GluN2B containing N-methyl-D-aspartate receptors 42
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 41
SYNTHESIS AND BIOLOGICAL CHARACTERIZATION OF 3-SUBSTITUTED-1H-INDOLES AS LIGANDS OF GLUN2B-CONTAINING N-METHYL-D-ASPARTATE RECEPTORS 39
SYNTHESIS AND BIOLOGICAL CHARACTERIZATION OF NEW NR2B/NMDA RECEPTOR LIGANDS 39
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: Synthesis, biological evaluation, and molecular modeling studies 38
Synthesis, Modelling and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-containing N-Methyl-d-Aspartate Receptors 38
Rational design, synthesis and evaluation of coumarin derivatives as protein-protein interaction inhibitors 38
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening 38
Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles. 27
Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-d-aspartate receptor (NMDAR) containing GluN2B subunit 27
Rational Design and synthesis of new GluN2B/NMDA receptor ligands as neuroprotective agents. 26
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-containing N-Methyl-D-Aspartate Receptors. Part. 2. 25
Totale 2.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 19 7 6 70 40 6
2020/2021274 15 6 54 11 29 12 11 45 31 40 10 10
2021/2022341 4 54 2 19 1 1 46 16 5 8 106 79
2022/2023730 46 65 33 75 57 61 14 30 328 2 16 3
2023/2024188 11 25 9 48 11 44 0 8 0 17 0 15
2024/2025143 15 8 15 45 42 14 4 0 0 0 0 0
Totale 2.136